Global Infectious Diseases Molecular Diagnostics Market to Remain Strong

The global infectious diseases MDx sector will continue to witness healthy growth in the coming years, forecasts RNCOS in its latest research study.

NOIDA, India (prHWY.com) June 5, 2012 - In the global molecular diagnostics (MDx) industry, molecular diagnostics for infectious diseases is one of the most rapidly growing market segments. According to a new research report by RNCOS, the infectious diseases diagnostics market accounts for the major share of the global MDx industry, and remains the largest revenue contributor. On back of factors, such as growing incidences of infectious diseases, active private sector participation, and technological advancements, the global infectious diseases molecular diagnostics market is estimated to witness a CAGR of around 10% during 2012-2015.

Research Analysis and Highlights

The report, "Infectious Disease Molecular Diagnostics Outlook 2015", provides an effective insight into the global infectious diseases molecular diagnostics market, and analyzes its current status and future position. It forecasts the market size for the period 2012-2015, and carefully analyzes key drivers and trends that will propel the market growth. The comprehensive study illustrates the current performance of the key infectious disease diagnostic segments (in terms of indications) to enumerate the vertical sector demand. It also analyzes the opportunities existing for companies in the market in terms of technologies, like PCR, RT-PCR, and NASBA, and disease prevalence. An in-depth insight into the FDA-approved diagnostics products, and recent industry developments have been included in the research report to provide a balanced outlook on the potentials of the global infectious diseases MDx sector.

Some of the report's key highlights include:

- HPV MDx market will boost the global infectious testing revenue patterns.
- RT-PCR the most preferred methods in the screening of infectious diseases.
- CT/GC testing will support the industry growth.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM411.htm

Some of our Related Reports are:

- Global API Market Analysis (http://www.rncos.com/Report/IM320.htm)
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally (http://www.rncos.com/Report/IM081.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: molecular diagnostics

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code